Wild-type TP53 can activate apoptosis-related pathways to induce cancer cell death and prevent tumour growth (10), whereas loss-of-function mutations in the TP53 gene can induce uncontrolled tumour cell proliferation (11, 12), as shown for oesophageal cancer (13, 14). Here, TP53 is linked to carcinoma of esophagus.